IIM
HRTX icon

INTECH Investment Management’s Heron Therapeutics HRTX Stock Holding History

INTECH Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Hold
42,150
– – ﹤0.01% 2108
2026
Q1 		$33.7K Sell
42,150
-17,219
-29% -$20K ﹤0.01% 2040
2025
Q4 		$77.2K Sell
59,369
-13,996
-19% -$17.3K ﹤0.01% 2205
2025
Q3 		$92.4K Sell
73,365
-21,446
-23% -$34K ﹤0.01% 2289
2025
Q2 		$196K Buy
94,811
+13,725
+17% +$28K ﹤0.01% 2095
2025
Q1 		$178K Buy
81,086
+22,844
+39% +$44.3K ﹤0.01% 2134
2024
Q4 		$89.1K Buy
58,242
+22,254
+62% +$36.1K ﹤0.01% 2234
2024
Q3 		$71.6K Buy
+35,988
New +$85.9K ﹤0.01% 1939

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

INTECH Investment Management's HRTX Position: Q2 2026 in Review

INTECH Investment Management held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 42,150 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

INTECH Investment Management first reported a position in HRTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $196K in Q2 2025. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • INTECH Investment Management held 42,150 shares of Heron Therapeutics worth $18K as of Q2 2026.
  • INTECH Investment Management left its Heron Therapeutics share count unchanged in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2108 holding.
  • INTECH Investment Management first reported a position in Heron Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Heron Therapeutics position peaked at $196K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.